China approves first-ever functional cure for hepatitis B

Published: Saturday, November 22, 2025 at 4:12 pm

China Approves Groundbreaking Hepatitis B Treatment

Beijing, China – In a significant development for global health, China has approved the world's first drug designed to achieve a functional cure for hepatitis B. The new therapy, named Pegbing, was developed by Amoytop Biotech. This marks a major advancement in the treatment of a disease that affects over 250 million people worldwide.

For decades, existing treatments for hepatitis B have primarily focused on managing the virus, effectively controlling its spread and mitigating its impact on the liver. However, these treatments have rarely been able to completely eliminate the virus from the body, leaving patients reliant on long-term medication and vulnerable to potential complications. Pegbing represents a departure from this approach, offering the potential for a functional cure. This means the drug aims to silence the virus, allowing the body to recover and potentially eliminating the need for ongoing medication.

The approval of Pegbing is a testament to the advancements in medical research and development. It offers hope to millions of individuals living with hepatitis B, potentially transforming their lives by freeing them from the burden of chronic medication and the associated health risks. The development of this new treatment underscores China's growing role in pharmaceutical innovation and its commitment to addressing global health challenges. The impact of this new drug will be closely watched by the medical community and patients worldwide.

BNN's Perspective: This approval is a positive step forward in the fight against hepatitis B. While it's crucial to acknowledge the potential benefits of Pegbing, it's also important to recognize that further research and real-world application will be necessary to fully understand its long-term efficacy and impact. The global community should closely monitor the drug's rollout and share data to ensure the best possible outcomes for patients.

Keywords: hepatitis B, Pegbing, China, functional cure, Amoytop Biotech, drug approval, medical breakthrough, global health, treatment, virus

Full Story